December 13, 2022 03:30 PM EST
Pharma
Manufacturing

In­done­si­a's state-owned phar­ma com­pa­ny strikes deal to man­u­fac­ture Mer­ck’s HPV vac­cine

Tyler Patchen

News Reporter

Cer­vi­cal can­cer is the sec­ond most fre­quent form of can­cer among women in In­done­sia. In ad­di­tion to rais­ing aware­ness and en­cour­ag­ing women to get the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Sanofi in­tro­duces new 340B pay­ment mod­el — re­port

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times